Home  »  Markets   »  Here are the top Institutional holders of Incyte C...

Here are the top Institutional holders of Incyte Corporation (INCY) shares

Incyte Corporation (NASDAQ: INCY) is 5.94% higher on its value in year-to-date trading and has touched a low of $62.31 and a high of $84.86 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INCY stock was last observed hovering at around $78.27 in the last trading session, with the day’s loss setting it -0.51% off its average median price target of $82.50 for the next 12 months. It is also 36.78% off the consensus price target high of $123.00 offered by 21 analysts, but current levels are -23.43% lower than the price target low of $63.00 for the same period.

Currently trading at $77.76, the stock is 1.56% and 8.28% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.15 million and changing -0.65% at the moment leaves the stock 4.98% off its SMA200. INCY registered 21.86% gain for a year compared to 6-month loss of 1.63%.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The stock witnessed a 7.37% gain in the last 1 month and extending the period to 3 months gives it a 6.99%, and is 1.37% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.12% over the week and 2.48% over the month.

Incyte Corporation (INCY) has around 2094 employees, a market worth around $17.41B and $3.33B in sales. Current P/E ratio is 19.76 and Fwd P/E is 19.81. Profit margin for the company is 26.30%. Distance from 52-week low is 24.81% and -8.37% from its 52-week high. The company has generated returns on investments over the last 12 months (25.30%).

Incyte Corporation (INCY) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Incyte Corporation (INCY) is a “Overweight”. 21 analysts offering their recommendations for the stock have an average rating of 2.30, where 9 rate it as a Hold and 2 think it is a “Overweight”. 9 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.

Incyte Corporation is expected to release its quarterly report on 02/16/2023.The EPS is expected to grow by 415.00% this year

Incyte Corporation (INCY) Top Institutional Holders

The shares outstanding are 222.41M, and float is at 218.93M with Short Float at 3.83%.

Incyte Corporation (INCY) Insider Activity

A total of 42 insider transactions have happened at Incyte Corporation (INCY) in the last six months, with sales accounting for 13 and purchases happening 29 times. The most recent transaction is an insider sale by Tray Thomas, the company’s Principal Accounting Officer. SEC filings show that Tray Thomas sold 1,564 shares of the company’s common stock on Jul 22 at a price of $83.13 per share for a total of $0.13 million. Following the sale, the insider now owns 17702.0 shares.

Incyte Corporation disclosed in a document filed with the SEC on Jul 07 that Flannelly Barry P (EVP & General Manager US) sold a total of 2,873 shares of the company’s common stock. The trade occurred on Jul 07 and was made at $79.38 per share for $0.23 million. Following the transaction, the insider now directly holds 72674.0 shares of the INCY stock.

Still, SEC filings show that on Jul 07, Iyengar Vijay K (EVP, GMAPPS) disposed off 5,787 shares at an average price of $79.38 for $0.46 million. The insider now directly holds 40,313 shares of Incyte Corporation (INCY).

Incyte Corporation (INCY): Who are the competitors?

The company’s main competitors (and peers) include Seagen Inc. (SGEN) that is trading -28.68% down over the past 12 months and Alnylam Pharmaceuticals Inc. (ALNY) that is 11.40% higher over the same period.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.